Three-way approach for precision strike against pancreatic cancer
Cancer Pancreatic Cancer T Cell

Three-way approach for precision strike against pancreatic cancer

Alejandro Noval
Alejandro Noval

London researchers have developed a three-pronged strategy to tackle pancreatic cancer by combining a drug and viruses that target cancer cells with immune cells from the patients, modified to specifically attack pancreatic cancer cells.

In 10 seconds? Scientists have reported positive preliminary results in lab mice with pancreatic cancer using a combination of a drug, genetically engineered viruses and immune cells.

Join the Sparrho Community

Sign up for our free newsletter or get full access to our library with a premium, paid subscription.

14 Day Free Trial

Get a 14 day, full-access free trial when signing up with a monthly or early membership.

Newsletter

No Cost
  • Access to subscriber posts
  • Regular newsletters
  • No ads
Free Newsletter

Monthly

$19 / mo
  • Be the first to read new digests, delivered to your inbox 5x/week
  • Unlimited access to all digests
  • Regular updates with new content
  • Simple, secure payments
  • Cancel anytime
  • No ads
14 Day Free Trial

Yearly

$99 / ye - 40% off
  • One easy payment - save 40%
  • Be the first to read new digests, delivered to your inbox 5x/week
  • Unlimited access to all digests
  • Regular updates with new content
  • Simple, secure payments
  • Cancel anytime
  • No ads
14 Day Free Trial